Mana Bio

Seed
mana.bio Biotech & Healthcare
Total Funding $20M
Latest Round $20M Seed
Last Announced Oct 17, 2023
Investors Undisclosed
Decision Makers 4 Verified

About Mana Bio

Mana.bio is an AI-based drug delivery startup specializing in programmable drug delivery and gene therapy, with a focus on lipid nanoparticles (LNPs), RNA-based therapeutics, DNA therapeutics, and vaccines.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website mana.bio
Domain Registered Date Feb 27, 2019

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $20,000,000 · Seed

    startupintros.com

  2. Milestone

    Website domain registered

    mana.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Mana Bio.

Funding History

1 Round
Seed · Oct 17, 2023

Founders & Leadership

4

Avi Schroeder

Scientific co-founder

Work email & phone locked Unlock →

Kira Radinsky

Scientific co-founder

Work email & phone locked Unlock →

Roy Nevo

Co-Founder & CTO

Work email & phone locked Unlock →

Yogev Debbi

Co-Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts